SLXN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silexion Therapeutics Corp (SLXN) is not a strong buy for a long-term beginner investor at this time. The company's financial performance is weak, with negative earnings and no significant revenue growth. Additionally, there are no positive catalysts such as news, insider activity, or trading signals to support a buy decision. The technical indicators also show a bearish trend, and the stock's short-term price forecast suggests limited upside potential. Given the lack of compelling reasons to invest and the user's preference for long-term growth, holding off on this stock is the best course of action.
The MACD is slightly positive but contracting, indicating weak momentum. The RSI is neutral at 24.378, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 0.94, and resistance is at 1.123. Overall, the technical indicators suggest a bearish trend.
NULL. There is no recent news, no insider or hedge fund activity, and no significant trading signals.
The company's financial performance is poor, with negative earnings and no revenue growth. The stock's short-term forecast indicates a potential decline over the next month.
In Q4 2025, revenue remained at 0 with no growth. Net income improved to -$4.41M, up 152.55% YoY, but EPS dropped significantly to -1.4, down 90.12% YoY. Gross margin is 0, showing no profitability.
No analyst ratings or price target changes are provided. Wall Street sentiment is unclear.
